跳至主要内容
临床试验/NL-OMON37665
NL-OMON37665招募中不适用

Evaluation of urinary concentrating defects in lithium treated patients with a dDAVP test - Nephrogenic diabetes insipidus (NDI) in lithium treated patients

niversitair Medisch Centrum Sint Radboud0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • stable patients with a mood disorder treated with lithium
  • men and women
  • age >= 18 years

排除标准

  • general contra-indications for participation in a trial:
  • inability to give informed consent
  • unstable psychiatric condition;alternative causes of (nephrogenic) diabetes insipidus:
  • hypo/hyperkalemia (plasma potassium < 3.5 or > 5.5 mmol/l)
  • severe hypercalcemia (albumin-corrected plasma calcium > 2.80 mmol/l)
  • hyperglycemia (plasma glucose > 10.0 mmol/l)
  • history of amyloidosis, Sjögren*s syndrome or Sickle cell anemia
  • previous treatment with ifosfamide
  • established primary polydipsia or central diabetes insipidus;contra-indications for dDAVP administration:
  • inability to comply with water restriction
  • renal insufficiency (GFR < 45 ml/min/1.73 m2)
  • hyponatremia (plasma sodium < 130 mmol/l) ;other:
  • concomitant treatment with desmopressin or democlocycline

研究者

发起方
niversitair Medisch Centrum Sint Radboud

相似试验